Similarly, the same gene can have oncogenic or tumor-suppressive functions in different tissues; for example, PARD3/Par3 overexpression is associated with renal cancers, but PARD3 downregulation or deletion is associated with breast, glioblastoma, lung, and other cancers (Halaoui and McCaffrey, 2015). This evidence concerns the gene PARD3 and cancer.